TY - JOUR AU - Schlenk, R. F. AU - Benner, A. AU - Krauter, J. AU - Büchner, T. AU - Sauerland, C. AU - Ehninger, G. PY - 2004 DA - 2004// TI - Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia InterGroup JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.03.012 DO - 10.1200/JCO.2004.03.012 ID - Schlenk2004 ER - TY - JOUR AU - Marcucci, G. AU - Mrózek, K. AU - Ruppert, A. S. AU - Maharry, K. AU - Kolitz, J. E. AU - Moore, J. O. PY - 2005 DA - 2005// TI - Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.15.610 DO - 10.1200/JCO.2005.15.610 ID - Marcucci2005 ER - TY - JOUR AU - Appelbaum, F. R. AU - Kopecky, K. J. AU - Tallman, M. S. AU - Slovak, M. L. AU - Gundacker, H. M. AU - Kim, H. T. PY - 2006 DA - 2006// TI - The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations JO - Br J Haematol VL - 135 UR - https://doi.org/10.1111/j.1365-2141.2006.06276.x DO - 10.1111/j.1365-2141.2006.06276.x ID - Appelbaum2006 ER - TY - JOUR AU - Yin, J. A. AU - O'Brien, M. A. AU - Hills, R. K. AU - Daly, S. B. AU - Wheatley, K. AU - Burnett, A. K. PY - 2012 DA - 2012// TI - Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial JO - Blood VL - 120 UR - https://doi.org/10.1182/blood-2012-06-435669 DO - 10.1182/blood-2012-06-435669 ID - Yin2012 ER - TY - JOUR AU - Jourdan, E. AU - Boissel, N. AU - Chevret, S. AU - Delabesse, E. AU - Renneville, A. AU - Cornillet, P. PY - 2013 DA - 2013// TI - Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-10-462879 DO - 10.1182/blood-2012-10-462879 ID - Jourdan2013 ER - TY - JOUR AU - Zhu, H. H. AU - Zhang, X. H. AU - Qin, Y. Z. AU - Liu, D. H. AU - Jiang, H. AU - Chen, H. PY - 2013 DA - 2013// TI - MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-11-468348 DO - 10.1182/blood-2012-11-468348 ID - Zhu2013 ER - TY - JOUR AU - Cornelissen, J. J. AU - Putten, W. L. AU - Verdonck, L. F. AU - Theobald, M. AU - Jacky, E. AU - Daenen, S. M. PY - 2007 DA - 2007// TI - Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2006-06-025627 DO - 10.1182/blood-2006-06-025627 ID - Cornelissen2007 ER - TY - JOUR AU - Lu, D. P. AU - Dong, L. AU - Wu, T. AU - Huang, X. J. AU - Zhang, M. J. AU - Han, W. PY - 2006 DA - 2006// TI - Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation JO - Blood VL - 107 UR - https://doi.org/10.1182/blood-2005-05-2146 DO - 10.1182/blood-2005-05-2146 ID - Lu2006 ER - TY - JOUR AU - Shimoni, A. AU - Labopin, M. AU - Savani, B. AU - Volin, L. AU - Ehninger, G. AU - Kuball, J. PY - 2016 DA - 2016// TI - Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning: a report on behalf of the acute leukemia working party of European group for blood and marrow transplantation JO - J Hematol Oncol VL - 9 UR - https://doi.org/10.1186/s13045-016-0347-1 DO - 10.1186/s13045-016-0347-1 ID - Shimoni2016 ER - TY - JOUR AU - Wang, Y. AU - Wu, D. P. AU - Liu, Q. F. AU - Qin, Y. Z. AU - Wang, J. B. AU - Xu, L. P. PY - 2014 DA - 2014// TI - In adults with t(8;21)AML, posttransplant RUNX1/RUNX1T1-based MRD monitoring, rather than c-KIT mutations, allows further risk stratification JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2014-03-563403 DO - 10.1182/blood-2014-03-563403 ID - Wang2014 ER - TY - JOUR AU - Yoon, J. H. AU - Kim, H. J. AU - Kim, J. W. AU - Jeon, Y. W. AU - Shin, S. H. AU - Lee, S. E. PY - 2014 DA - 2014// TI - Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation JO - Bone Marrow Transplant VL - 49 UR - https://doi.org/10.1038/bmt.2014.180 DO - 10.1038/bmt.2014.180 ID - Yoon2014 ER - TY - JOUR AU - Weisser, M. AU - Haferlach, C. AU - Hiddemann, W. AU - Schnittger, S. PY - 2007 DA - 2007// TI - The quality of molecular response to chemotherapy is predictive for the outcome of AML1-ETO-positive AML and is independent of pretreatment risk factors JO - Leukemia VL - 21 UR - https://doi.org/10.1038/sj.leu.2404659 DO - 10.1038/sj.leu.2404659 ID - Weisser2007 ER - TY - JOUR AU - Leroy, H. AU - Botton, S. AU - Grardel-Duflos, N. AU - Darre, S. AU - Leleu, X. AU - Roumier, C. PY - 2005 DA - 2005// TI - Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21) JO - Leukemia VL - 19 UR - https://doi.org/10.1038/sj.leu.2403627 DO - 10.1038/sj.leu.2403627 ID - Leroy2005 ER - TY - JOUR AU - Willekens, C. AU - Blanchet, O. AU - Renneville, A. AU - Cornillet-Lefebvre, P. AU - Pautas, C. AU - Guieze, R. PY - 2016 DA - 2016// TI - Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial JO - Haematologica VL - 101 UR - https://doi.org/10.3324/haematol.2015.131946 DO - 10.3324/haematol.2015.131946 ID - Willekens2016 ER - TY - JOUR AU - Lane, S. AU - Saal, R. AU - Mollee, P. AU - Jones, M. AU - Grigg, A. AU - Taylor, K. PY - 2008 DA - 2008// TI - A > or = 1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor acute myeloid leukemia and predicts subsequent morphologic relapse JO - Leuk Lymphoma VL - 49 UR - https://doi.org/10.1080/10428190701817266 DO - 10.1080/10428190701817266 ID - Lane2008 ER - TY - JOUR AU - Tobal, K. AU - Newton, J. AU - Macheta, M. AU - Chang, J. AU - Morgenstern, G. AU - Evans, P. A. PY - 2000 DA - 2000// TI - Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse JO - Blood VL - 95 ID - Tobal2000 ER - TY - JOUR AU - Sugimoto, T. AU - Das, H. AU - Imoto, S. AU - Murayama, T. AU - Gomyo, H. AU - Chakraborty, S. PY - 2000 DA - 2000// TI - Quantitation of minimal residual disease in t(8;21)-positive acute myelogenous leukemia patients using real-time quantitative RT-PCR JO - Am J Hematol VL - 64 UR - https://doi.org/3.0.CO;2-X DO - 3.0.CO;2-X ID - Sugimoto2000 ER - TY - JOUR AU - Mitterbauer, M. AU - Mitterbauer-Hohendanner, G. AU - Sperr, W. R. AU - Kalhs, P. AU - Greinix, H. T. AU - Fonatsch, C. PY - 2004 DA - 2004// TI - Molecular disease eradication is a prerequisite for long-term remission in patients with t(8;21) positive acute myeloid leukemia: a single center study JO - Leuk Lymphoma VL - 45 UR - https://doi.org/10.1080/10428190310001638913 DO - 10.1080/10428190310001638913 ID - Mitterbauer2004 ER - TY - JOUR AU - Grimwade, D. AU - Walker, H. AU - Oliver, F. AU - Wheatley, K. AU - Harrison, C. AU - Harrison, G. PY - 1998 DA - 1998// TI - The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children’s Leukaemia Working Parties JO - Blood VL - 92 ID - Grimwade1998 ER - TY - JOUR AU - Qin, Y. Z. AU - Zhu, H. H. AU - Jiang, Q. AU - Jiang, H. AU - Zhang, L. P. AU - Xu, L. P. PY - 2014 DA - 2014// TI - Prevalence and prognostic significance of c-KIT mutations in core binding factor acute myeloid leukemia: a comprehensive large-scale study from a single Chinese center JO - Leuk Res VL - 38 UR - https://doi.org/10.1016/j.leukres.2014.09.017 DO - 10.1016/j.leukres.2014.09.017 ID - Qin2014 ER - TY - JOUR AU - Yan, C. H. AU - Liu, D. H. AU - Liu, K. Y. AU - Xu, L. P. AU - Liu, Y. R. AU - Chen, H. PY - 2012 DA - 2012// TI - Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2011-09-380386 DO - 10.1182/blood-2011-09-380386 ID - Yan2012 ER - TY - JOUR AU - Mo, X. D. AU - Zhang, X. H. AU - Xu, L. P. AU - Wang, Y. AU - Yan, C. H. AU - Chen, H. PY - 2015 DA - 2015// TI - Interferon-α: a potentially effective treatment for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation JO - Biol Blood Marrow Transplant VL - 21 UR - https://doi.org/10.1016/j.bbmt.2015.06.014 DO - 10.1016/j.bbmt.2015.06.014 ID - Mo2015 ER - TY - JOUR AU - Beillard, E. AU - Pallisgaard, N. AU - Velden, V. H. AU - Bi, W. AU - Dee, R. AU - Schoot, E. PY - 2003 DA - 2003// TI - Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program JO - Leukemia VL - 17 UR - https://doi.org/10.1038/sj.leu.2403136 DO - 10.1038/sj.leu.2403136 ID - Beillard2003 ER - TY - JOUR AU - Gabert, J. AU - Beillard, E. AU - Velden, V. H. AU - Bi, W. AU - Grimwade, D. AU - Pallisgaard, N. PY - 2003 DA - 2003// TI - Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia—a Europe Against Cancer program JO - Leukemia VL - 17 UR - https://doi.org/10.1038/sj.leu.2403135 DO - 10.1038/sj.leu.2403135 ID - Gabert2003 ER - TY - JOUR AU - Paschka, P. AU - Marcucci, G. AU - Ruppert, A. S. AU - Mrózek, K. AU - Chen, H. AU - Kittles, R. A. PY - 2006 DA - 2006// TI - Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2006.06.9500 DO - 10.1200/JCO.2006.06.9500 ID - Paschka2006 ER - TY - JOUR AU - Walter, R. B. AU - Buckley, S. A. AU - Pagel, J. M. AU - Wood, B. L. AU - Storer, B. E. AU - Sandmaier, B. M. PY - 2013 DA - 2013// TI - Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission JO - Blood VL - 122 UR - https://doi.org/10.1182/blood-2013-06-506725 DO - 10.1182/blood-2013-06-506725 ID - Walter2013 ER - TY - JOUR AU - Araki, D. AU - Wood, B. L. AU - Othus, M. AU - Radich, J. P. AU - Halpern, A. B. AU - Zhou, Y. PY - 2016 DA - 2016// TI - Allogeneic hematopoietic cell transplantation for acute myeloid leukemia: time to move toward a minimal residual disease-based definition of complete remission? JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2015.63.3826 DO - 10.1200/JCO.2015.63.3826 ID - Araki2016 ER - TY - JOUR AU - Wang, Y. AU - Liu, D. H. AU - Xu, L. P. AU - Liu, K. Y. AU - Chen, H. AU - Chen, Y. H. PY - 2011 DA - 2011// TI - Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high-risk acute leukemia: an historic comparison JO - Biol Blood Marrow Transplant VL - 17 UR - https://doi.org/10.1016/j.bbmt.2010.08.023 DO - 10.1016/j.bbmt.2010.08.023 ID - Wang2011 ER -